» Articles » PMID: 36700121

Characterization of the Humanized FRG Mouse Model and Development of an AAV-LK03 Variant with Improved Liver Lobular Biodistribution

Abstract

Recent clinical successes have intensified interest in using adeno-associated virus (AAV) vectors for therapeutic gene delivery. The liver is a key clinical target, given its critical physiological functions and involvement in a wide range of genetic diseases. In the present study, we first investigated the validity of a liver xenograft mouse model repopulated with primary hepatocytes using single-nucleus RNA sequencing (sn-RNA-seq) by studying the transcriptomic profile of human hepatocytes pre- and post-engraftment. Complementary immunofluorescence analyses performed in highly engrafted animals confirmed that the human hepatocytes organize and present appropriate patterns of zone-dependent enzyme expression in this model. Next, we tested a set of rationally designed HSPG de-targeted AAV-LK03 variants for relative transduction performance in human hepatocytes. We used immunofluorescence, next-generation sequencing, and single-nucleus transcriptomics data from highly engrafted FRG mice to demonstrate that the optimally HSPG de-targeted AAV-LK03 displayed a significantly improved lobular transduction profile in this model.

Citing Articles

Mice Engrafted with Human Liver Cells.

de Jong Y Semin Liver Dis. 2024; 44(4):405-415.

PMID: 39265638 PMC: 11620938. DOI: 10.1055/s-0044-1790601.


Enhanced AAV transduction across preclinical CNS models: A comparative study in human brain organoids with cross-species evaluations.

Drouyer M, Merjane J, Nedelkoska T, Westhaus A, Scott S, Lee S Mol Ther Nucleic Acids. 2024; 35(3):102264.

PMID: 39108635 PMC: 11301180. DOI: 10.1016/j.omtn.2024.102264.


Correlation of antigen expression with epigenetic modifications after rAAV delivery of a human factor IX variant in mice and rhesus macaques.

Pekrun K, Stephens C, Gonzalez-Sandoval A, Goswami A, Zhang F, Tarantal A Mol Ther. 2024; 32(7):2064-2079.

PMID: 38715361 PMC: 11286812. DOI: 10.1016/j.ymthe.2024.05.005.


Harnessing whole human liver ex situ normothermic perfusion for preclinical AAV vector evaluation.

Cabanes-Creus M, Liao S, Navarro R, Knight M, Nazareth D, Lau N Nat Commun. 2024; 15(1):1876.

PMID: 38485924 PMC: 10940703. DOI: 10.1038/s41467-024-46194-y.


Development of CNS tropic AAV1-like variants with reduced liver-targeting following systemic administration in mice.

Drouyer M, Merjane J, Nazareth D, Knight M, Scott S, Liao S Mol Ther. 2024; 32(3):818-836.

PMID: 38297833 PMC: 10928139. DOI: 10.1016/j.ymthe.2024.01.024.


References
1.
Grimm D, Lee J, Wang L, Desai T, Akache B, Storm T . In vitro and in vivo gene therapy vector evolution via multispecies interbreeding and retargeting of adeno-associated viruses. J Virol. 2008; 82(12):5887-911. PMC: 2395137. DOI: 10.1128/JVI.00254-08. View

2.
Kietzmann T . Metabolic zonation of the liver: The oxygen gradient revisited. Redox Biol. 2017; 11:622-630. PMC: 5257182. DOI: 10.1016/j.redox.2017.01.012. View

3.
Pillay S, Meyer N, Puschnik A, Davulcu O, Diep J, Ishikawa Y . An essential receptor for adeno-associated virus infection. Nature. 2016; 530(7588):108-12. PMC: 4962915. DOI: 10.1038/nature16465. View

4.
Worner T, Bennett A, Habka S, Snijder J, Friese O, Powers T . Adeno-associated virus capsid assembly is divergent and stochastic. Nat Commun. 2021; 12(1):1642. PMC: 7955066. DOI: 10.1038/s41467-021-21935-5. View

5.
Sonntag F, Kother K, Schmidt K, Weghofer M, Raupp C, Nieto K . The assembly-activating protein promotes capsid assembly of different adeno-associated virus serotypes. J Virol. 2011; 85(23):12686-97. PMC: 3209379. DOI: 10.1128/JVI.05359-11. View